Presymptomatic dosing of the substituted pyrimidine, KP544, reduces behavioral deficits in the R6/2 mouse model of Huntington's disease

R A Myers, Gary Dunbar

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish
Title of host publication2005 Abstract Viewer/Itinerary Planner
PublisherSociety for Neuroscience
StatePublished - 2005

Fingerprint

Dive into the research topics of 'Presymptomatic dosing of the substituted pyrimidine, KP544, reduces behavioral deficits in the R6/2 mouse model of Huntington's disease'. Together they form a unique fingerprint.

Cite this